AstraZeneca foregoes early settlement of Japan Iressa legal cases
This article was originally published in Scrip
Executive Summary
AstraZeneca has decided not to accept a court-proposed settlement in Japan in legal cases relating to side-effects during the use of its lung cancer drug Iressa (gefitinib).